Navari, Rudolph M <br/><br/>
Crossover safety study of aprepitant: 2-min injection vs 30-min infusion in cancer patients receiving emetogenic chemotherapy.  [electronic resource] 

 -  OncoTargets and therapy  2019 
 - 3277-3284 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1178-6930 
<br/><br/><label>Standard No.: </label>10.2147/OTT.S201609  doi